Three centers experience with device closure of congenital Gerbode-type perimembranous ventricular septal defects.
Adolescent
Adult
Aortic Valve Insufficiency
/ etiology
Cardiac Catheterization
/ adverse effects
Child
Child, Preschool
Female
Heart Septal Defects, Ventricular
/ diagnostic imaging
Humans
Middle Aged
Retrospective Studies
Septal Occluder Device
Treatment Outcome
Tricuspid Valve Insufficiency
/ etiology
Young Adult
Gerbode defect
device closure
perimembranous ventricular septal defect
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
17
04
2022
accepted:
21
05
2022
pubmed:
1
7
2022
medline:
4
8
2022
entrez:
30
6
2022
Statut:
ppublish
Résumé
We aim to evaluate our experience with interventional closure of Gerbode-type perimembranous ventricular septal defects (pmVSDs). We performed three-center retrospective data review of patients with congenital indirect Gerbode-type pmVSDs treated percutaneously between August 2017 and May 2021. Standard safety and latest follow-up outcomes were assessed. Ten patients (six females) were identified with a median age of 6.8 years (range: 2.5-54) and a median weight of 26.5 kg (range: 12-88). The median left ventricular defect size was 10 mm (range: 3-15.5). On baseline ultrasound, 6 patients had absent subaortic rim , 6 patients had trivial aortic regurgitation, and 3 patients had tear-drop-type (small) aortic cusp prolapse. The tricuspid regurgitation was graded II (n = 5) and III (n = 5). Five Lifetech Konar-Multifunctional occluders, four Amplatzer duct occluders II and one Amplatzer duct occluder I were implanted. The median fluoroscopy time was 10.4 min (range: 4.3-20.2). Pre-existing aortic regurgitations remained identical. One new aortic regurgitation was identified before discharge and remained trivial after 48 months of follow-up. No heart block or tricuspid stenosis was observed on a median follow-up of 17 months (range: 3-48). All patients are symptom-free with complete shunt closure and significant regression or resolution of tricuspid regurgitation. Despite anatomical challenges, interventional closure of congenital indirect Gerbode-type pmVSD appears to be feasible, safe, and most importantly clinically effective using different commercially available devices. Amplatzer duct occluder II and Lifetech Konar-Multifunctional occluder offer interesting specifications to retrogradely target this specific defect with success.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2714-2724Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Gerbode F, Hultgren H, Melrose D, Osborn J. Syndrome of left ventricular-right atrial shunt; successful surgical repair of defect in five cases, with observation of bradycardia on closure. Ann Surg. 1958;148(3):433-446. doi:10.1097/00000658-195809000-00012
Riemenschneider TA, Moss AJ. Left ventricular-right atrial communication. Am J Cardiol. 1967;19(5):710-718. doi:10.1016/0002-9149(67)90476-6
Jacobs JP, Burke RP, Quintessenza JA, Mavroudis C. Congenital heart surgery nomenclature and database project: ventricular septal defect. Ann Thorac Surg. 2000;69(4 suppl):S25-S35. doi:10.1016/s0003-4975(99)01270-9
Freedom RM, White RD, Pieroni DR, Varghese PJ, Krovetz LJ, Rowe RD. The natural history of the so-called aneurysm of the membranous ventricular septum in childhood. Circulation. 1974;49(2):375-384. doi:10.1161/01.cir.49.2.375
Leung MP, Mok CK, Lo RN, Lau KC. An echocardiographic study of perimembranous ventricular septal defect with left ventricular to right atrial shunting. Br Heart J. 1986;55(1):45-52. doi:10.1136/hrt.55.1.45
Wu MH, Chang CI, Wang JK, Lue HC. Characterization of aneurysmal transformation in perimembranous ventricular septal defects: an adhered anterior leaflet of tricuspid valve predisposes to the development of left ventricular-to-right atrial shunt. Int J Cardiol. 1994;47(2):117-125. doi:10.1016/0167-5273(94)90177-5
Hagler DJ, Squarcia U, Cabalka AK, Connolly HM, O'Leary PW. Mechanism of tricuspid regurgitation in paramembranous ventricular septal defect. J Am Soc Echocardiogr. 2002;15(4):364-368. doi:10.1067/mje.2002.116335
Sinisalo JP, Sreeram N, Jokinen E, Qureshi SA. Acquired left ventricular-right atrium shunts. Eur J Cardiothorac Surg. 2011;39(4):500-506. doi:10.1016/j.ejcts.2010.04.027
Saker E, Bahri GN, Montalbano MJ, et al. Gerbode defect: a comprehensive review of its history, anatomy, embryology, pathophysiology, diagnosis, and treatment. J Saudi Heart Assoc. 2017;29(4):283-292. doi:10.1016/j.jsha.2017.01.006
Yuan SM. A systematic review of acquired left ventricle to right atrium shunts (Gerbode defects). Hellenic J Cardiol. 2015;56(5):357-372.
Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014;63(12):1159-1168. doi:10.1016/j.jacc.2014.01.008
Saurav A, Kaushik M, Mahesh Alla V, et al. Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2015;86(6):1048-1056. doi:10.1002/ccd.26097
Tehrani F, Movahed MR. How to prevent echocardiographic misinterpretation of Gerbode type defect as pulmonary arterial hypertension. Eur J Echocardiogr. 2007;8(6):494-497. doi:10.1016/j.euje.2006.07.014
Haddad RN, Daou L, Saliba Z. Device closure of perimembranous ventricular septal defect: choosing between amplatzer occluders. Front Pediatr. 2019;7:300. doi:10.3389/fped.2019.00300
Haddad RN, Daou LS, Saliba ZS. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: midterm outcomes of the first middle-eastern experience. Catheter Cardiovasc Interv. 2020;96(3):E295-E302. doi:10.1002/ccd.28678
Yacoub MH, Mansur A, Towers M, Westbury H. Bacterial endocarditis complicating left ventricle to right atrium communication. Br J Dis Chest. 1972;66(1):78-82.
Yuan SM. Left ventricular to right atrial shunt (Gerbode defect): congenital versus acquired. Postepy Kardiol Interwencyjnej. 2014;10(3):185-194. doi:10.5114/pwki.2014.45146
Breatnach CR, Walsh KP. Ruptured sinus of Valsalva aneurysm and Gerbode defects: patient and procedural selection: the key to optimising outcomes. Curr Cardiol Rep. 2018;20(10):90. doi:10.1007/s11886-018-1038-z
Taskesen T, Prouse AF, Goldberg SL, Gill EA. Gerbode defect: another nail for the 3D transesophagel echo hammer? Int J Cardiovasc Imaging. 2015;31(4):753-764. doi:10.1007/s10554-015-0620-3
Trehan V, Ramakrishnan S, Goyal NK. Successful device closure of an acquired Gerbode defect. Catheter Cardiovasc Interv. 2006;68(6):942-945. doi:10.1002/ccd.20896
Kerst G, Moysich A, Ho SY, Apitz C, Latus H, Schranz D. Transcatheter closure of perimembranous ventricular septal defects with left ventricular to right atrial shunt. Pediatr Cardiol. 2015;36(7):1386-1392. doi:10.1007/s00246-015-1170-0
Vijayalakshmi IB, Natraj Setty HS, Chitra N, Manjunath CN. Amplatzer duct occluder II for closure of congenital Gerbode defects. Catheter Cardiovasc Interv. 2015;86(6):1057-1062. doi:10.1002/ccd.26020
Ganesan G, Paul GJ, Mahadevan VS. Transcatheter closure of left ventricle to right atrial communication using cera duct occluder. Indian Heart J. 2017;69(3):341-344. doi:10.1016/j.ihj.2017.01.011
Phan QT, Kim SW, Nguyen HL. Percutaneous closure of congenital Gerbode defect using Nit-Occlud® Lê VSD coil. World J Cardiol. 2017;9(7):634-639. doi:10.4330/wjc.v9.i7.634
Haddad RN, Gaudin R, Bonnet D, Malekzadeh-Milani S. Hybrid perventricular muscular ventricular septal defect closure using the new multi-functional occluder. Cardiol Young. 2020;30(10):1517-1520. doi:10.1017/S1047951120002401
Haddad RN, Rizk C, Saliba Z, Farah J. Percutaneous closure of ventricular septal defects in children: key parameters affecting patient radiation exposure. Am J Cardiovasc Dis. 2021;11(1):65-72.
Yang R, Kong XQ, Sheng YH, et al. Risk factors and outcomes of post-procedure heart blocks after transcatheter device closure of perimembranous ventricular septal defect. JACC Cardiovasc Interv. 2012;5(4):422-427. doi:10.1016/j.jcin.2012.01.015
Sinisalo J, Sreeram N, Qureshi SA. Transcatheter closure of acquired left ventricle to right atrium shunts. Catheter Cardiovasc Interv. 2013;82(6):E809-E814. doi:10.1002/ccd.24917
Leong MC, Alwi M. Complete atrio-ventricular heart block, a not to be forgotten complication in transcatheter closure of perimembranous ventricular septal defect-a case report and review of literature. Cardiol Young. 2021;31:1-4. doi:10.1017/S1047951121001980
Ghosh S, Sridhar A, Sivaprakasam M. Complete heart block following transcatheter closure of perimembranous VSD using Amplatzer duct occluder II. Catheter Cardiovasc Interv. 2018;92(5):921-924. doi:10.1002/ccd.27177
Cinteză EE, Butera G. Complex ventricular septal defects. Update on percutaneous closure. Rom J Morphol Embryol. 2016;57(4):1195-1205.